Allergy Immunotherapy for the Reduction of Asthma (AIR)
|ClinicalTrials.gov Identifier: NCT01028560|
Recruitment Status : Suspended (No evidence of clinically meaningful benefits for asthma (reduction of asthma medication scores and symptoms) in preliminary analysis)
First Posted : December 9, 2009
Last Update Posted : July 1, 2015
Albert Einstein College of Medicine, Inc.
Jacobi Medical Center
Information provided by (Responsible Party):
Gabriele de Vos, Albert Einstein College of Medicine of Yeshiva University
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Suspended|
|Primary Completion Date :||April 2015|
|Study Completion Date :||No date given|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
de Vos G, Nazari R, Ferastraoaru D, Parikh P, Geliebter R, Pichardo Y, Wiznia A, Rosenstreich D. Discordance between aeroallergen specific serum IgE and skin testing in children younger than 4 years. Ann Allergy Asthma Immunol. 2013 Jun;110(6):438-43. doi: 10.1016/j.anai.2013.03.006. Epub 2013 Apr 11.
de Vos G, Shankar V, Nazari R, Kooragayalu S, Smith M, Wiznia A, Rosenstreich D. Fear of repeated injections in children younger than 4 years receiving subcutaneous allergy immunotherapy. Ann Allergy Asthma Immunol. 2012 Dec;109(6):465-9. doi: 10.1016/j.anai.2012.10.003. Erratum in: Ann Allergy Asthma Immunol. 2013 Mar;110(3):216.